MyMD Pharmaceuticals Company Overview
About MyMD Pharmaceuticals
MyMD Pharmaceuticals (NASDAQ:MYMD) specializes in developing innovative treatments that aim to extend human healthy lifespan by focusing on age-related diseases and immune disorders. The company invests heavily in research and development of therapies that target key markers involved in chronic inflammation and immune dysregulation, areas that contribute significantly to the aging process and the onset of many age-related diseases. With projects like MYMD-1, a drug designed to delay aging and increase longevity, and Supera-CBD, a synthetic cannabinoid derivative with potential therapeutic benefits over natural CBD, MyMD Pharmaceuticals is at the forefront of translating groundbreaking science into potentially life-extending treatments. The company's objectives revolve around advancing these projects through clinical trials to market, striving to profoundly impact public health by addressing conditions associated with aging.
Snapshot
Operations
Produtos e/ou serviços de MyMD Pharmaceuticals
- MYMD-1, an oral immune system regulator aimed at treating aging and age-related diseases including autoimmune diseases and COVID-19.
- Supera-CBD, a synthetic cannabidiol (CBD) derivative designed to be more potent than natural CBD for therapeutic applications.
- A research project focused on developing therapies for fibrosis, leveraging the anti-inflammatory and anti-fibrotic properties of their proprietary compounds.
- An initiative exploring MYMD-1's potential in prolonging healthspan by targeting key aging-related biomarkers and pathways.
- Clinical trials investigating the efficacy of MYMD-1 in treating Multiple Sclerosis (MS) due to its immune modulating properties.
- Development of a novel drug delivery platform aimed at enhancing the bioavailability and efficacy of their therapeutic compounds.
equipe executiva do MyMD Pharmaceuticals
- Mr. Ian Rhodes CPAInterim Chief Financial Officer
- Dr. Jenna Brager M.S., Ph.D., R.N.Executive Vice President of Drug Development
- Dr. Mitchell Glass M.D.President, Chief Medical Officer & Director